Scheme

Baroda BNP Paribas Health and Wellness Fund

Holds 33 companies worth ₹473 Cr in Sept 2026.

Fund house
BNPThe fund house that runs this scheme.
AUM
₹487 CrBaroda BNP Paribas Health and Wellness Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 4.0% on Aug 2026, ₹507 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 8.6% of this scheme's NAV.
Fund manager
Rohan KordeRuns it since 1 May 2026, as the fund house dates it. With Ankeet Pandya (fund manager).

Holdings^{(Jun 2025 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	33 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	41.8
	Torrent Pharmaceuticals Limited	38.4
	Divi s Laboratories Limited	38.1
	IPCA Laboratories Limited	29.9
	Laurus Labs Limited	29.7
	Lupin	28.2
	Apollo Hospitals Enterprise Limited	25.7
	Fortis Healthcare Limited	19.4
	Dr Lal Path Labs Limited	16.9
	Mankind Pharma Limited	16.3
	Glenmark Pharmaceuticals	15.2
	Aurobindo Pharma	15.1
	Astra IDL Ltd	13.6
	Abbott India Limited	12.2
	Emcure Pharmaceuticals Limited	11.7
	Acutaas Chemicals Limited	11.5
	Cadila Healthcare	10.9
	Max Financial Services Limited	10.8
	Aster DM Healthcare Limited	10.5
	Concord Biotech Limited	10.3
	Ajanta Pharmaceuticals Limited	7.6
	Symbiotec Pharmalab Limited	7.2
	Nephrocare Health Services Ltd	6.9
	Metropolis Healthcare Limited	6.5
	Dr Reddy s Laboratories Limited	6.2
	Manipal Health Enterprises Ltd	6
	Gland Pharma Limited	5.8
	Cipla	5.4
	Narayana Hrudayalaya Limited	4.8
	Inventurus Knowledge Solutions Limited	4.4
	GLAXO SMITHKLINE PHARMA	3.3
	LIC of India Ltd	2.3
	Procter Gamble Health Limited	0.85

Sun Pharmaceutical Ind Ltd
Torrent Pharmaceuticals Lim…

Market value of each ticked company in Baroda BNP Paribas Health and Wellness Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Torrent Pharmaceuticals Limited
Sept 2025	₹65.4 Cr	₹23.4 Cr
Oct 2025	₹57.5 Cr	₹23.1 Cr
Nov 2025	₹55 Cr	₹24.2 Cr
Dec 2025	₹42.1 Cr	₹25 Cr
Jan 2026	₹46.3 Cr	₹25.8 Cr
Feb 2026	₹52.1 Cr	₹28.2 Cr
Mar 2026	₹52.7 Cr	₹27.4 Cr
Apr 2026	₹49.7 Cr	₹27.2 Cr
May 2026	₹49.5 Cr	₹28.7 Cr
Jun 2026	₹41.9 Cr	₹30 Cr
Jul 2026	₹45.8 Cr	₹44.6 Cr
Aug 2026	₹45.7 Cr	₹40.5 Cr
Sept 2026	₹41.8 Cr	₹38.4 Cr

Fig. 1.Market value of each ticked company in Baroda BNP Paribas Health and Wellness Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	6	31.13

Mid Cap	15	45.10

Small Cap	10	18.13

Unlisted	2	2.70

Cash & others		2.94

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	2.3L	41.8	8.58
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	80K	38.4	7.88
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	41K	38.1	7.82
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.55L	29.9	6.13
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	1.5L	29.7	6.09
Lupin	Equity	Pharmaceuticals & Biotechnology	1.39L	28.2	5.79
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	31.5K	25.7	5.28
Fortis Healthcare Limited	Equity	Healthcare Services	2.52L	19.4	3.98
Dr Lal Path Labs Limited	Equity	Healthcare Services	85K	16.9	3.47
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	65K	16.3	3.34
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	65K	15.2	3.11
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	90K	15.1	3.09
Astra IDL Ltd	Equity	Pharmaceuticals & Biotechnology	22K	13.6	2.79
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	4.5K	12.2	2.50
Emcure Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	60K	11.7	2.39
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	35K	11.5	2.36
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	94K	10.9	2.24
Max Financial Services Limited	Equity	Insurance	78.5K	10.8	2.21
Aster DM Healthcare Limited	Equity	Healthcare Services	1.5L	10.5	2.15
Concord Biotech Limited	Equity	Pharmaceuticals & Biotechnology	75K	10.3	2.11
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	21K	7.6	1.56
Symbiotec Pharmalab Limited	Equity	Pharmaceuticals & Biotechnology	60.7K	7.2	1.47
Nephrocare Health Services Ltd	Equity	Healthcare Services	1.05L	6.9	1.42
Metropolis Healthcare Limited	Equity	Healthcare Services	1.2L	6.5	1.33
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	50K	6.2	1.26
Manipal Health Enterprises Ltd	Equity	Healthcare Services	84.8K	6	1.23
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	20K	5.8	1.19
Cipla	Equity	Pharmaceuticals & Biotechnology	40K	5.4	1.10
Narayana Hrudayalaya Limited	Equity	Healthcare Services	26.5K	4.8	0.97
Inventurus Knowledge Solutions Limited	Equity	IT - Services	25K	4.4	0.90
GLAXO SMITHKLINE PHARMA	Equity	Pharmaceuticals & Biotechnology	12K	3.3	0.68
LIC of India Ltd	Equity	Insurance	57.7K	2.3	0.47
Procter Gamble Health Limited	Equity	Pharmaceuticals & Biotechnology	1.53K	0.85	0.17

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.